SCHEMBL1702302

SCHEMBL1702302

COc1ccc(CNC2(Cc3ccccc3)CCC(=O)CC2)cc1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.48
NPC1 O15118 2/20 0.45
KCNA3 P22001 1/20 0.45
RAB9A P51151 1/20 0.44
NR3C1 P04150 1/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
ATM Q13315 1/20 0.43
ALDH1A1 P00352 4/20 0.43
LTA4H P09960 1/20 0.43
AR P10275 2/20 0.41
KDM4E B2RXH2 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
NR3C2 P08235 1/20 0.41
SIGMAR1 Q99720 1/20 0.40
USP2 O75604 1/20 0.40
KDM1A O60341 1/20 0.40
MAPT P10636 1/20 0.40
MAPK1 P28482 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11091179 0.81 KCNA3 (0.41) HTTKCNA3NR3C1ALDH1A1LTA4H
SCHEMBL1702723 0.80 ALDH1A1 (0.47) HTTNPC1RAB9AMEN1KMT2A
SCHEMBL3561618 0.80 ALDH1A1 (0.43) HTTNPC1KCNA3RAB9AMEN1
SCHEMBL23023159 0.75 MAOA (0.47) HTTMEN1KMT2AALDH1A1KDM4E
SCHEMBL11096449 0.71 KCNA3 (0.46) HTTNPC1KCNA3RAB9ANR3C1
SCHEMBL3570132 0.71 ALDH1A1 (0.40) MEN1KMT2AALDH1A1KDM4ESMN1; SMN2
SCHEMBL23022883 0.71 L3MBTL1 (0.45) HTTMEN1KMT2AALDH1A1KDM1A
SCHEMBL11073700 0.71 CHRM2 (0.46) HTTMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL11092391 0.71 ALDH1A1 (0.43) HTTKCNA3NR3C1MEN1KMT2A
SCHEMBL23023104 0.70 PLA2G1B (0.47) NPC1RAB9AALDH1A1KDM4EKDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2121691-B1 SPIROCYCLIC CYCLOHEXANE DERIVATIVES GRUENENTHAL GMBH (DE) 2012-04-18 EP disclosed
US-7960404-B2 Spirocyclic cyclohexane compounds GRUENENTHAL GMBH (DE) 2011-06-14 US disclosed
US-20100048553-A1 Spirocyclic Cyclohexane Compounds GRUENENTHAL GMBH (DE) 2010-02-25 US disclosed
EP-2121691-A1 SPIROCYCLIC CYCLOHEXANE DERIVATIVES Grünenthal GmbH (DE) 2009-11-25 EP disclosed
WO-2008101660-A1 SPIROCYCLIC CYCLOHEXANE DERIVATIVES Grünenthal GmbH (DE) 2008-08-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048553-A1 Spirocyclic Cyclohexane Compounds PKD2, PKD1, RYR1 HTT 458/4885NPC1 291/4885KCNA3 847/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.